[The efferent substitution correction of blood trace element disorder in patients with chronic kidney failure].
Reasons are given for expediency of correction of dystraceelementemia in chronic renal insufficiency. Following exposure to the treatment with the multivitaminotraceelement drug three-we PLUS and alpha-erythropoietin eprex patients with terminal renal failure prolonged by chronic hemodialysis (n = 16) demonstrated a decrease in blood concentration of toxic trace elements and in dysbalance of essential trace elements, alleviation of clinical symptoms, increased tolerance to physical loads, improvement of hematological indices and quality of life.
Nykula
T D
TD
Krasiuk
I V
IV
D003131:Combined Modality Therapy; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D016061:Enterosorption; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D011994:Recombinant Proteins; D006435:Renal Dialysis; D014131:Trace Elements / Q000097:blood* / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D004338:Drug Combinations; D011994:Recombinant Proteins; D014131:Trace Elements; D014815:Vitamins; D004921:Erythropoietin